Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage

Recruiting N/A Interventional Study
Intracerebral Hemorrhage Nontraumatic Intracerebral Hemorrhage
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
15 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of an acute spontaneous ICH based on non-contrast CT * Time from symptom onset to anticipated start of cerebral DSA of under 3 hours * Agreement of the treating physician to perform DSA * Informed consent documented by signature or fulfilling the criteria for emergen…
Contacts

Alex Brehm, PhD

+41 61 328 79 48

alex.brehm@usb.ch

CONTACT

Marios-Nikos Psychogios, Prof Dr

+41 61 328 59 36

marios.psychogios@usb.ch

CONTACT